WHO recommends GSK-Vir and Lilly’s drugs for Covid-19 treatment
GSK-Vir’s sotrovimab was demonstrated to retain activity against Omicron variant in initial laboratory studies.
Switzerland
Latest in
Switzerland
CSL to acquire Switzerland’s Vifor Pharma for $11.7bn
On acquisition, the merged company will have a pipeline of 37 products at various stages of development.
Novartis records 6% growth in third quarter 2021 sales
Noticing a drop in Sandoz sales, the company initiated an assessment of this division to explore options.
WHO recommends use of Regeneron’s Covid-19 antibody drug cocktail
The development is based on a British trial in 9,000 subjects, in which the antibody cocktail lowered mortality in hospitalised…
Novavax and SII seek WHO emergency use listing for Covid-19 vaccine
WHO authorisation is a prerequisite to supply the vaccine to several countries that are part of the COVAX Facility.
NeuExcell and Spark partner to develop gene therapy for Huntington’s
Under the agreement, Spark will access the neuro-regenerative gene therapy platform of NeuExcell to develop the new treatment.
Eagle to licence Combioxin’s antitoxin agent for pneumonia treatment
Combioxin is eligible for both upfront and milestone payments from Eagle on out-licensing the commercial rights to CAL02.
Genevant and Takeda to develop gene therapies for liver diseases
Genevant’s lipid nanoparticle technology will be leveraged by Takeda to create novel nonviral gene therapies.